Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network

(2009) E. Terpos et al.   ANNALS OF ONCOLOGY

Editorial Board

(2009)   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan

(2008) C. I. Ripamonti et al.   ANNALS OF ONCOLOGY

Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma

(2008) Ashraf Badros et al.   JOURNAL OF CLINICAL ONCOLOGY

Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates

(2008) Vittorio Montefusco et al.   LEUKEMIA & LYMPHOMA

The dilemma of jaw osteonecrosis in patients with multiple myeloma

(2008) Morie A. Gertz et al.   LEUKEMIA & LYMPHOMA

Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution

(2008) Nicla La Verde et al.   SUPPORTIVE CARE IN CANCER